DrugInfoSys

Hyaluronidase

Drug #361

Hyaluronidase is enzyme that catalyzes the breakdown of hyaluronic acid. Hyaluronidase is found in the mammalian testicular and spleen tissues, in bees and snake venoms and in certain species of Clostridium, Staphylococcus and Streptococcus. Hyaluronidase is used clinically to facilitate the administration of fluid by hypodermoclysis. Hyaluronidase is used to render the tissues more readily pormeable to injected fluids e.g for introduction of fluids by sub-cutaneously infusion.

Primary Characteristics

It is of Natural origin and belongs to CHO.

It belongs to Hyaluronidase Enzyme pharmacological group on the basis of mechanism of action and also classified in Enzyme pharmacological group. It is also classified under Antidotes .

Molecular Weight: 6100000000 · pKa: 8.6 0000000 · Solubility in Water: readily soluble · Solubility in Alcohol: Insoluble · Non-proprietary name: Hyaluronidase.

Molecular structure of Hyaluronidase

Pharmacokinetics

Elimination: it is metabolised via Hepatic, plasma half-life is 3.2 min, renal excretion is partial.

Advertisement

Indications

Contraindications

Hyaluronidase is contraindicated in conditions like Infections.

Dosage

Hyaluronidase's dosage details are as follows:

DoseSingle DoseFrequencyRouteInstructions
Adult Dosage
1500 IU1500 IUIM,SCPer Infusion or As Required
Paediatric Dosage (20kg)
1500 IU1500 IUIntra Muscular Total Dose
Neonatal Dosage (3kg)
1500 IU1500 IUIntra Muscular Total Dose

Drug Interactions

Unknown2 interactions

Always consult your physician for the change of dose regimen or an alternative drug of choice that may strictly be required.

Side Effects

Hyaluronidase produces potentially life-threatening effects which include Hypersensitivity reactions, Anaphylactic shock. Careful monitoring is needed with proper medical management.

Hyaluronidase is known to cause more or less tolerable side effects which are usually transient. These include Bleeding , Bruising , Edema, Local irritation.

Warnings / Precautions

Hyaluronidase should not be administered by intravenous injection. It should not be applied directly to cornea. It should not be used to reduce the swelling of bites or stings.It should be cauutiously given to infants and elderly not for intra venous administration.

Interference in Pathology

Hyaluronidase may interfere in the diagnosis of None well documented.

Available Brands

Click on a strength to view available brands.

Single Ingredient

Storage Conditions

Hyaluronidase should be stored Inj.

Drug Classification

  1. 1.21.7Other ophthalmologicals

Manufacturers

Manufacturers of Hyaluronidase in Pakistan: